Article Versions Notes

Konstantopoulos G, Leventakou D, Saltiel D-R, Zervoudi E, Logotheti E, Pettas S, Karagianni K, Daiou A, Hatzistergos KE, Dafou D, et al. HPV16 E6 Oncogene Contributes to Cancer Immune Evasion by Regulating PD-L1 Expression through a miR-143/HIF-1a Pathway. Viruses. 2024; 16(1):113. https://doi.org/10.3390/v16010113

Konstantopoulos, Georgios, Danai Leventakou, Despoina-Rozi Saltiel, Efthalia Zervoudi, Eirini Logotheti, Spyros Pettas, Korina Karagianni, Angeliki Daiou, Konstantinos E. Hatzistergos, Dimitra Dafou, and et al. 2024. "HPV16 E6 Oncogene Contributes to Cancer Immune Evasion by Regulating PD-L1 Expression through a miR-143/HIF-1a Pathway" Viruses 16, no. 1: 113. https://doi.org/10.3390/v16010113

Konstantopoulos, G., Leventakou, D., Saltiel, D.-R., Zervoudi, E., Logotheti, E., Pettas, S., Karagianni, K., Daiou, A., Hatzistergos, K. E., Dafou, D., Arsenakis, M., Psyrri, A., & Kottaridi, C. (2024). HPV16 E6 Oncogene Contributes to Cancer Immune Evasion by Regulating PD-L1 Expression through a miR-143/HIF-1a Pathway. Viruses, 16(1), 113. https://doi.org/10.3390/v16010113